| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 02/28/1992 | WO1992003538A1 METHODS FOR PRODUCING RNA VIRUSES FROM cDNA |
| 02/27/1992 | DE4026964A1 New infectious acid-resistant rhinovirus strain - is e.g. mutant of serotype 14; for treating rhinovirus infection |
| 02/21/1992 | CA2067337A1 Methods for producing rna viruses from cdna |
| 02/20/1992 | WO1992002548A1 Recombinant baculovirus expressing proteins e and ns1 of flaviviridae viruses and flaviviridae-related viruses |
| 02/19/1992 | EP0471028A1 Highly cytopathogenic hiv-ndk retrovirus, dna fragments of this retrovirus, method for preparing a protein and/or an enzyme of this virus, and the applications of these |
| 02/16/1992 | WO1992003051A1 Inhibition of herpesviridae infection by antisense oligonucleotides |
| 02/16/1992 | CA2089476A1 Inhibition of herpesviridae infection by antisense oligonucleotides |
| 02/06/1992 | WO1992001816A1 Human herpesvirus-7 |
| 02/06/1992 | WO1992001784A1 Rotavirus reassortant vaccine |
| 02/06/1992 | WO1992001471A1 Methods of use of bovine respiratory syncytial virus recombinant dna, proteins vaccines, antibodies, and transformed cells |
| 02/06/1992 | CA2087853A1 Methods of use of bovine respiratory syncytial virus recombinant dna, proteins vaccines, antibodies, and transformed cells |
| 02/05/1992 | EP0469089A1 Generation of hybrid genes and proteins by virus-mediated recombination |
| 02/04/1992 | US5085781 Porous calcium phosphate granules |
| 02/03/1992 | WO1992002628A1 Expression of human cmv glycoprotein-h using the baculovirus-insect cell expression system |
| 02/03/1992 | WO1992002251A1 Herpes simplex virus vp16 vaccines |
| 02/03/1992 | CA2088599A1 Expression of human cmv glycoprotein-h using the baculovirus-insect cell expression system |
| 01/29/1992 | EP0468714A2 Peptide-polysaccharide-protein conjugate vaccines |
| 01/23/1992 | WO1992001047A1 Methods for producing members of specific binding pairs |
| 01/23/1992 | WO1992001045A1 Equine herpesvirus-4 tk- vaccine |
| 01/23/1992 | WO1992000987A1 Primate lentivirus vaccines |
| 01/23/1992 | CA2086740A1 Equine herpesvirus-4 tk-vaccine |
| 01/22/1992 | EP0467349A1 Regulation of gene expression by employing translational inhibition utilizing mRNA interfering complementary RNA |
| 01/22/1992 | EP0466815A1 Infectious targetted replication-defective virion |
| 01/20/1992 | CA2047031A1 Peptide-polysaccharide-protein conjugate vaccines |
| 01/17/1992 | CA2047091A1 Method for producing gene protein products |
| 01/15/1992 | EP0223840B1 Nucleic acid probes for prenatal sexing |
| 01/14/1992 | CA1294231C Method of producing peptides |
| 01/08/1992 | EP0464137A1 Inhibition of hiv using synergistic combinations of nucleoside derivatives |
| 01/07/1992 | US5079342 Diagnosis of AIDS |
| 01/03/1992 | WO1992000372A1 Recombinant pigeon pox virus vaccine |
| 01/03/1992 | CA2084064A1 Recombinant pigeon pox virus vaccine |
| 01/02/1992 | EP0463712A2 Polynucleotide phosphorodithioates as therapeutic agents for retroviral infections |
| 12/31/1991 | US5077213 Recombinant vaccinia virus |
| 12/28/1991 | CA2036287A1 Polynucleotide phosphorodithioate as therapeutic agents for retroviral infections |
| 12/26/1991 | WO1991019803A1 Self assembled, defective, nonself-propagating viral particles |
| 12/26/1991 | WO1991019785A1 THE RETROVIRUS SIVcpz-ant AND ITS USES |
| 12/26/1991 | CA2085370A1 The retrovirus siv cpz-ant and its uses |
| 12/21/1991 | WO1991019818A1 Peptide library and screening systems |
| 12/21/1991 | WO1991019798A1 Vectors containing hiv packaging sequences, packaging defective hiv vectors, and uses thereof |
| 12/21/1991 | CA2084659A1 Vectors containing hiv packaging sequences, packaging defective hiv vectors, and uses thereof |
| 12/21/1991 | CA2084411A1 Peptide library and screening systems |
| 12/20/1991 | WO1991019795A1 Nonpathogenic variant virus |
| 12/20/1991 | WO1991019786A1 Type-c rotavirus cultures and uses therefor |
| 12/20/1991 | CA2085897A1 Nonpathogenic variant virus |
| 12/20/1991 | CA2076396A1 Type-c rotavirus cultures and uses therefor |
| 12/12/1991 | WO1991018922A1 16 kDa SURFACE PROTEIN OF $i(P. FALCIPARUM) |
| 12/12/1991 | WO1991018627A1 Swine pneumonia vaccine and method for the preparation thereof |
| 12/11/1991 | EP0460056A1 Non-a, non-b hepatitis hepatocyte cell culture |
| 12/10/1991 | US5071758 Veterinary medicine |
| 12/10/1991 | US5071757 Incubating human tissue susceptible to the virus, placing it beneath renal capsule in immunocompromised animal and determining the effect of tissue |
| 12/04/1991 | EP0459842A1 Process for the production of retroviral immunogenes and vaccines against retroviral infections, especially HIV, and immunogens and vaccines thereof |
| 12/04/1991 | EP0157852B1 Inviable phages, their production and dna thereof |
| 12/03/1991 | US5069901 Deactivated antigens |
| 11/28/1991 | WO1991018089A1 Association between a human immunodeficiency virus-related retrovirus and sjogren's syndrome |
| 11/27/1991 | EP0349593B1 Method of producing high aqueous volume multilamellar vesicles |
| 11/26/1991 | US5068192 Attenuated pseudorabies virus which includes foreign DNA encoding an amino acid sequence |
| 11/21/1991 | EP0457196A2 Photodynamic inactivation of viruses in cell-containing compositions |
| 11/19/1991 | US5066782 Retrovirus capable of causing AIDS, means and method for detecting it in vitro |
| 11/14/1991 | WO1991017271A1 Recombinant library screening methods |
| 11/14/1991 | WO1991016911A1 Decontamination of whole blood and cellular components by phenthiazin-5-ium-dyes plus light |
| 11/13/1991 | EP0455695A1 Retroviral vector and its use in the production of transgenic animals |
| 11/12/1991 | US5064646 In poultry, which will not bind to monoclonal antibodies that bind to current vaccines; live or killed vaccines |
| 11/10/1991 | CA2042085A1 Process for the preparation of retrovirus immunogens and vaccines against retroviral, notably hiv, infections and obtained immunogens and vaccines |
| 10/31/1991 | WO1991016420A1 Methods of preventing viral replication |
| 10/31/1991 | WO1991016060A1 Method of inactivation of viral and bacterial blood contaminants |
| 10/31/1991 | CA2081022A1 Methods of preventing viral replication |
| 10/30/1991 | EP0453556A1 Pneumocystis carinii dihydrofolate reductase gene and methods for its use |
| 10/22/1991 | CA1291056C Process for growing granulosis viruses |
| 10/17/1991 | WO1991006658A3 Infective protein delivery system |
| 10/08/1991 | US5055391 Method and kit or detecting antibodies to antigens of human immunodeficiency virus type 2 (hiv-2) |
| 10/04/1991 | WO1991015574A1 Purified hcv and hcv proteins and peptides |
| 10/04/1991 | CA2079677A1 Purified hcv and hcv proteins and peptides |
| 10/03/1991 | WO1991015593A1 Polypeptides useful in diagnosis of and treatment against mycoplasma infections in animals |
| 10/03/1991 | CA2078131A1 Polypeptides useful in diagnosis of and treatment against mycoplasma infections in animals |
| 09/24/1991 | US5051496 Polypeptides encoded by DNA fragments for detection of AIDS |
| 09/24/1991 | CA1289420C Method of producing high aqueous volume multilamellar vesicles |
| 09/22/1991 | WO1991014436A1 Reagents and methods for modulating gene expression through rna mimicry |
| 09/22/1991 | CA2078659A1 Reagents and methods for modulating gene expression through rna mimicry |
| 09/18/1991 | EP0447303A1 Recombinant herpes viruses, particularly for realization of vaccines, preparation process therefor, realized plasmids during this process and obtained vaccines |
| 09/13/1991 | WO1991013995A1 Recombinant herpesviruses in particular for the production of vaccines, their preparation process, plasmides produced during this process and the vaccines obtained |
| 09/13/1991 | CA2055489A1 Recombinant herpesviruses in particular for the production of vaccines, their preparation process, plasmides produced during this process and the vaccines obtained |
| 09/05/1991 | WO1991012811A1 Oligonucleotide therapies for modulating the effects of herpesviruses |
| 09/05/1991 | WO1991011525A3 Vaccines |
| 09/05/1991 | CA2074523A1 Oligonucleotide therapies for modulating the effects of herpesviruses |
| 09/04/1991 | EP0444638A2 Process for the expression of human nerve growth factor in arthropoda frugiperda cells by infection with recombinant baculovirus |
| 09/04/1991 | CN1054192A Process for preparing inducing interferon of human body |
| 08/29/1991 | WO1991013088A1 Terminally blocked antiviral peptides |
| 08/29/1991 | CA2077088A1 Terminally blocked antiviral peptides |
| 08/28/1991 | EP0443335A1 Recombinant pox virus plasmid containing a multi-functional DNA cassette |
| 08/27/1991 | US5043262 Screening for HIV-1 virus |
| 08/27/1991 | CA1288075C Fermentation methods for hepatitis vaccine production |
| 08/22/1991 | WO1991012318A1 Recombinant poxvirus internal cores |
| 08/21/1991 | EP0441897A1 Parvovirus capsids |
| 08/20/1991 | US5041379 Gene expression under control of heliothis promoters |
| 08/15/1991 | CA2033757A1 Recombinant poxvirus internal cores |
| 08/14/1991 | WO1991012079A1 Method to isolate macromolecules using magnetically attractable beads which do not specifically bind the macromolecules |
| 08/14/1991 | EP0440607A1 Microencapsulated insecticidal pathogens |
| 08/14/1991 | CA2071846A1 Method to isolate macromolecules using magnetically attractable beads which do not specifically bind the macromolecules |
| 08/13/1991 | WO1991012020A1 Novel vaccine and method therefor |
| 08/13/1991 | US5039483 Antiprotozoan method |